Pharmaron Beijing Co (HKSE:03759) FCF Margin % : 9.25% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pharmaron Beijing Co's Free Cash Flow for the three months ended in Mar. 2024 was HK$268 Mil. Pharmaron Beijing Co's Revenue for the three months ended in Mar. 2024 was HK$2,901 Mil. Therefore, Pharmaron Beijing Co's FCF Margin % for the quarter that ended in Mar. 2024 was 9.25%.

As of today, Pharmaron Beijing Co's current FCF Yield % is 1.22%.

The historical rank and industry rank for Pharmaron Beijing Co's FCF Margin % or its related term are showing as below:

HKSE:03759' s FCF Margin % Range Over the Past 10 Years
Min: -50.16 Med: -2.32 Max: 6.48
Current: 3.4

During the past 10 years, the highest FCF Margin % of Pharmaron Beijing Co was 6.48%. The lowest was -50.16%. And the median was -2.32%.

HKSE:03759's FCF Margin % is ranked better than
81.25% of 1040 companies
in the Biotechnology industry
Industry Median: -137.43 vs HKSE:03759: 3.40

Pharmaron Beijing Co FCF Margin % Historical Data

The historical data trend for Pharmaron Beijing Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co FCF Margin % Chart

Pharmaron Beijing Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

4.90

6.48

-0.47

-7.86

-0.97

Pharmaron Beijing Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-9.35	1.17	0.32	3.34	9.25

Competitive Comparison of Pharmaron Beijing Co's FCF Margin %

For the Biotechnology subindustry, Pharmaron Beijing Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaron Beijing Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's FCF Margin % falls into.

Pharmaron Beijing Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pharmaron Beijing Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-122.265	/	12620.016
	=	-0.97 %

Pharmaron Beijing Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	268.328	/	2901.23
	=	9.25 %

Pharmaron Beijing Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaron Beijing Co (HKSE:03759) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (HKSE:03759) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

PHBBF:USA 300759:China

Address

No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Hong Kong, HKG

Website

https://www.pharmaron.com

Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. The company generates maximum revenue from Laboratory services segment.

Executives

Morgan Stanley	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Citigroup Inc.	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you
Gic Private Limited	2102 Investment manager
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you
Matthews International Capital Management, Llc	2102 Investment manager
First H Share Award And Scheme Of Pharmaron Beijing Co., Ltd.	2301 Trustee
Kastle Limited	2301 Trustee
Jian Xin Bei Jing Tou Zi Ji Jin Guan Li You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Jian Xin Xin Tuo You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you

Pharmaron Beijing Co (HKSE:03759) Headlines

No Headlines